Alpar Horvath
Overview
Explore the profile of Alpar Horvath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Horvath A, Farkas A, Reti I, Ilyes N, Havadtoi B, Kovacs T, et al.
Respir Med
. 2024 Dec;
236:107916.
PMID: 39701396
The aim of this study was to analyse the effect of breathing parameters, age, gender and disease status on the lung doses of the two ICS + LABA fixed combination...
2.
Analysis of COPD: Distinguishing Characteristics and Management of Smoking vs Never Smoking Patients
Fekete M, Horvath A, Santa B, Abonyi-Toth Z, Tomisa G, Szollosi G, et al.
Int J Chron Obstruct Pulmon Dis
. 2024 Dec;
19:2671-2688.
PMID: 39677832
Background: Chronic obstructive pulmonary disease (COPD) is a significant public health issue characterized by gradually worsening airflow limitation. It is a leading cause of mortality and morbidity worldwide, yet research...
3.
Nagy A, Czitrovszky A, Lehoczki A, Farkas A, Furi P, Osan J, et al.
Geroscience
. 2024 Oct;
47(1):543-571.
PMID: 39392557
Hospital- and nursing-care-acquired infections are a growing problem worldwide, especially during epidemics, posing a significant threat to older adults in geriatric settings. Intense research during the COVID-19 pandemic highlighted the...
4.
Sudi A, Santa B, Horvath A, Tomisa G, Abonyi-Toth Z, Rokszin G, et al.
Int J Chron Obstruct Pulmon Dis
. 2024 Sep;
19:1943-1955.
PMID: 39219564
Purpose: COPD affects more than 300 million people worldwide, requiring inhalation treatment. Novel triple formulations of ICS, LABAs and LAMAs are becoming the mainstay of treatment, however there is still...
5.
Lazar Z, Horvath A, Kiss-Dala S, Abonyi-Toth Z, Csoma B, Kontz K, et al.
Eur Clin Respir J
. 2024 Mar;
11(1):2328434.
PMID: 38529514
Background: The criteria for significant bronchodilator responsiveness (BDR) were published in 2005 by the European Respiratory Society/American Thoracic Society, which were revised in 2021, however, data on the agreement between...
6.
Tomisa G, Santa B, Horvath A, Nemeth L, Tamas B, Galffy G, et al.
BMJ Open Respir Res
. 2024 Feb;
11(1).
PMID: 38413122
Introduction: Asthma is the most prevalent obstructive pulmonary disease, with drastically improved treatment options over the past decades. However, there is still a proportion of patients with suboptimal level of...
7.
Farkas A, Horvath A, Reti I, Ilyes N, Havadtoi B, Kovacs T, et al.
Respir Med
. 2024 Feb;
224:107576.
PMID: 38403127
The deposition of dry powder aerosol drugs depends on the inhalation parameters of the patients through the inhaler. These data are not directly measured in clinical practice. Their prediction based...
8.
Farkas A, Tomisa G, Szenasi G, Furi P, Kugler S, Nagy A, et al.
Int J Pharm X
. 2023 Jul;
6:100192.
PMID: 37405278
The amount of drug depositing in the airways depends, among others, on the inhalation manoeuvre and breathing parameters. The objective of this study was to quantify the effect of lung...
9.
Abidi Y, Fekete M, Farkas A, Horvath A, Varga J
Physiol Int
. 2023 May;
110(2):89-107.
PMID: 37235454
Functional conditions like lung function and exercise capacity are important limiting factors of chest surgery in lung cancer with co-morbidities (chronic obstructive pulmonary disease (COPD) and other chronic respiratory diseases)....
10.
Fekete M, Horvath A, Santa B, Tomisa G, Szollosi G, Varga J
Ann Palliat Med
. 2023 Apr;
12(3):516-528.
PMID: 37038057
Background: In chronic obstructive pulmonary disease (COPD), uptake of the coronavirus disease 2019 (COVID-19) booster vaccine is important, as they are more likely to develop serious complications. Our aim was...